Celanese CORP (Form: 3, Received: 03/13/2008 19:40:45)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*
ODwyer John
2. Date of Event Requiring Statement (MM/DD/YYYY) 3/3/2008
3. Issuer Name and Ticker or Trading Symbol
Celanese CORP [CE]

(Last)        (First)        (Middle)
C/O CELANESE CORPORATION, 1601 W. LBJ FREEWAY
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
EVP Supply Management /

(Street)
DALLAS, TX 75234

(City)              (State)              (Zip) 5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security
(Instr. 4) 2. Amount of Securities Beneficially Owned
(Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Series A Common Stock 63431 D

Series A Common Stock 6761 I By 401(k) Plan

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)

1. Title of Derivate Security
(Instr. 4) 2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 6. Nature of Indirect Beneficial Ownership
(Instr. 5)

Date Exercisable Expiration Date Title Amount or Number of Shares

Employee Stock Option (right to buy) ⁽¹⁾ 1/21/2015 Series A Common Stock 105353 $16 D

Employee Stock Option (right to buy) ⁽²⁾ 1/21/2015 Series A Common Stock 184632 $16.00 D

Phantom Stock ⁽³⁾ ⁽³⁾ Series A Common Stock 13159.44 ⁽⁴⁾ D

Explanation of Responses:

(1) Granted pursuant to the Company's 2004 Stock Incentive Plan. The options vested with respect to 15% of the Option Shares on January 21, 2005; with respect to 20% on each of December 31, 2005, December 31, 2006 and December 31, 2007; and subject to continued employment, will continue to vest with respect to 20% on December 31, 2008, and with respect to the remaining 5% on March 31, 2009.

(2) Granted pursuant to the Company's 2004 Stock Incentive Plan. The options vested with respect to 15% of the Option Shares on Janurary 21, 2005; with respect to 30% on each of December 31, 2005 and December 2006; with respect to 15% of such Option Shares on December 31, 2007 and subject to continued employment and the achievement of certain performance targets 10% will vest on December 31, 2008.

(3) Granted pursuant to the Company's Revised Deferred Compensation Plan (as amended on April 2, 2007), each share of Phantom Stock represents the right to receive the cash value of one share of Series A Common Stock.

(4) Subject to continued employment, the shares of Phantom Stock shall become fully vested and will be payable in cash on December 31, 2010.

Remarks:
Exhibit List: Exhibit 24.1 Power of Attorney

Reporting Owners

Reporting Owner Name / Address Relationships

Director 10% Owner Officer Other

ODwyer John
C/O CELANESE CORPORATION
1601 W. LBJ FREEWAY
DALLAS, TX 75234

EVP Supply Management

Signatures

/s/ Robert L. Villasenor, Attorney -In-Fact for John A. O'Dwyer 3/13/2008

^** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table I - Non-Derivative Securities Beneficially Owned
Series A Common Stock	63431	D
Series A Common Stock	6761	I	By 401(k) Plan

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
Employee Stock Option (right to buy)	⁽¹⁾	1/21/2015	Series A Common Stock	105353	$16	D
Employee Stock Option (right to buy)	⁽²⁾	1/21/2015	Series A Common Stock	184632	$16.00	D
Phantom Stock	⁽³⁾	⁽³⁾	Series A Common Stock	13159.44	⁽⁴⁾	D

LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
Know all by these presents that the undersigned hereby makes, constitutes and appoints Robert Villasenor, Alexander Ludlow or Curtis S. Shaw as the undersigned's true

and lawful attorney-in-fact, with full power and authority as

hereinafter described on behalf of and in the name, place and stead of the undersigned to:
(1)prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5 (including any amendments thereto) with respect to the securities of Celanese Corporation, a Delaware corporation (the "Company"), with the United States Securities and Exchange Commission and any national securities exchanges, as considered necessary or advisable under Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as amended from time to time (the "Exchange Act");
(2) seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in Celanese's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information; and
(3) perform any and all other acts which in the discretion of such attorney-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing. The undersigned acknowledges that:
(1) this Power of Attorney authorizes, but does not require, such attorney-in-fact to act in their discretion on information provided to such attorney-in-fact without independent verification of such information;
(2) any documents prepared and/or executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable;
(3) neither Celanese nor such attorneys-in-fact assumes
(i) any liability for the undersigned's responsibility to comply with the requirement of the Exchange Act,
(ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under
Section 16(b) of the Exchange Act; and(4) this Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act. The undersigned hereby gives and grants the foregoing attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, hereby ratifying all that such attorney-in-fact of, for and on behalf of the undersigned, will lawfully do or cause to be done by virtue of this Power of Attorney. This Power of Attorney will remain in full force and effect until revoked by the undersigned in a signed writing delivered to such attorney-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date set forth below.

/s/John A. O'Dwyer
Signature

Name: John A. O'Dwyer
Dated: 3/4/08

Witness:

/s/Robert L. Villasenor
Signature

Name: Robert L. Villasenor
Dated: 3/4/08

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Series A Common Stock	63431	D
Series A Common Stock	6761	I	By 401(k) Plan

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	⁽¹⁾	1/21/2015	Series A Common Stock	105353	$16	D
Employee Stock Option (right to buy)	⁽²⁾	1/21/2015	Series A Common Stock	184632	$16.00	D
Phantom Stock	⁽³⁾	⁽³⁾	Series A Common Stock	13159.44	⁽⁴⁾	D

Explanation of Responses:
(1)	Granted pursuant to the Company's 2004 Stock Incentive Plan. The options vested with respect to 15% of the Option Shares on January 21, 2005; with respect to 20% on each of December 31, 2005, December 31, 2006 and December 31, 2007; and subject to continued employment, will continue to vest with respect to 20% on December 31, 2008, and with respect to the remaining 5% on March 31, 2009.
(2)	Granted pursuant to the Company's 2004 Stock Incentive Plan. The options vested with respect to 15% of the Option Shares on Janurary 21, 2005; with respect to 30% on each of December 31, 2005 and December 2006; with respect to 15% of such Option Shares on December 31, 2007 and subject to continued employment and the achievement of certain performance targets 10% will vest on December 31, 2008.
(3)	Granted pursuant to the Company's Revised Deferred Compensation Plan (as amended on April 2, 2007), each share of Phantom Stock represents the right to receive the cash value of one share of Series A Common Stock.
(4)	Subject to continued employment, the shares of Phantom Stock shall become fully vested and will be payable in cash on December 31, 2010.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
ODwyer John C/O CELANESE CORPORATION 1601 W. LBJ FREEWAY DALLAS, TX 75234			EVP Supply Management

Signatures
/s/ Robert L. Villasenor, Attorney -In-Fact for John A. O'Dwyer		3/13/2008
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.